Yahoo Web Search

Search results

  1. May 2, 2024 · Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Stock Information. KYMR. May 15, 2024. $35.47. + 0.38/+1.08% Data Provided by Refinitiv.

  2. May 2, 2024 · KYMR | Complete Kymera Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

  3. 3 days ago · Kymera Therapeutics Inc. KYMR:US. Nasdaq GM (USD) · Market closed. 36.01. +1.06 +3.03% As of 8:00 PM EDT 05/20/24. Prev. close. 34.95 USD. 36.01 USD. 3:58 PM. 9:30a 10:30a 11:30a 12:30p 1:30p...

  4. www.nasdaq.com › market-activity › stocksKYMR - Nasdaq

    Discover real-time Kymera Therapeutics, Inc. Common Stock (KYMR) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

  5. 2 days ago · with Phase 1 data in the first half of 2025. WATERTOWN, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new ...

  6. View the latest Kymera Therapeutics Inc. (KYMR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

  7. A high-level overview of Kymera Therapeutics, Inc. (KYMR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

  1. People also search for